Trio-Tech International Common Stock
AMEX: TRT · TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS
Updated 2026-11-03
Trio-Tech International Common Stock (TRT) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for TRT.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
TRT historical valuation range
Where current P/E sits in TRT's own 5Y range.
TRT intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
TRT valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
P/S Ratio — History
Current: 0.84x
Is TRT overvalued in 2026?
Trio-Tech International Common Stock (TRT) currently trades at $4.85 per share with a market capitalization of $52,339,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 34/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
TRT currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 0.8x, the market is valuing the company primarily on its revenue rather than its earnings.
Looking at its own history, TRT is currently trading cheaper than 100% of the last 5Y on P/E. This places it in the 0th percentile of its historical range, a level that has historically coincided with attractive entry points.
Our discounted cash flow model estimates TRT's intrinsic value at $3.83 per share, against the current market price of $4.85. This implies a premium to fair value of -54.83%. The current price sits well above what projected cash flows justify, implying investors are paying for growth that has not yet materialized.
The Piotroski F-Score of 4/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: TRT appears richly valued on our framework, with a Smart Value Score of 34/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is TRT overvalued?
TRT scores 34/100 on our Smart Value Score (Grade F), a weak overall profile. On valuation specifically, the DCF puts intrinsic value below the current price, so the stock is expensive on cash flow today. The score reflects growth and quality carrying it, not a cheap entry point.
What is TRT's fair value?
Our DCF model estimates TRT's intrinsic value at $3.83 per share, versus the current price of $4.85, a margin of safety of -54.83%. Fair value is the present value of the cash flows we project the business to produce, so a price above it means the market is paying up for growth the model does not yet assume.
What P/E ratio does TRT trade at?
TRT does not have a meaningful P/E right now, usually a sign of unprofitability or an earnings transition. For unprofitable growth names, price-to-sales is the more useful gauge.
Is TRT a buy based on valuation?
Our Smart Value rating for TRT is Strong Sell, from a Smart Value Score of 34/100 that blends growth, quality, and valuation. The profile skews cautious, and a better price or clearer operating improvement would strengthen the case. This is research to inform your decision, not personalized financial advice.
How does TRT's valuation compare to its history?
On P/E, TRT sits in the 0th percentile of its own 5Y range, historically cheap relative to where it has traded. A low percentile means today's multiple is near the bottom of its historical band.
What is TRT's Smart Value Score?
TRT's Smart Value Score is 34/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.